Paper2420009
Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells.
Souza LM and 14 others. Science, 1986. Cited by 1,335 papers, by iCite.
Cite this record
ConductScience Library. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Papers, record 2420009. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2420009
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colony-Stimulating Factors | Major topic |
| Granulocytes | Major topic |
| Leukemia | Major topic |
| Recombinant Proteins | Major topic |
| Animals | |
| Cell Differentiation | |
| Cell Line | |
| Colony-Forming Units Assay | |
| DNA | |
| Escherichia coli | |
| Genes | |
| Granulocyte Colony-Stimulating Factor | |
| Humans | |
| Leukemia, Myeloid | |
| Mice | |
| Plasmids |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA00966 | NCI NIH HHS | United States | K08CA000966 | PubMed and NIH | NIH RePORTER |
| CA20194 | NCI NIH HHS | United States | P01CA020194 | PubMed and NIH | NIH RePORTER |
| CA32516 | NCI NIH HHS | United States | R01CA032516 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01933971 | Evaluation of Dose-response, Pharmacodynamic and Pharmacokinetic Bioequivalence of Filgrastim in Healthy Male Volunteers After Single and Multiple-dose Subcutaneous Administration of the Test Injectable Formulation BK0023 vs. Neupogen® | Background |
Source ClinicalTrials.gov
Cited by221
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,335 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42178347 | Evaluation of bone mineral density in patients with severe congenital neutropenia: experience of six centers in Turkey. | Sci Rep | 2026 | https://conductscience.org/library/papers/42178347 | PubMed |
| 41981080 | Blood cell-derived transplants at 40. | Bone Marrow Transplant | 2026 | https://conductscience.org/library/papers/41981080 | PubMed |
| 39638788 | Neutrophil diversity and function in health and disease. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39638788 | PubMed |
| 39009900 | Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer. | Int J Clin Oncol | 2024 | https://conductscience.org/library/papers/39009900 | PubMed |
| 38814416 | Progress in the treatment of Osteoarthritis with avocado-soybean unsaponifiable. | Inflammopharmacology | 2024 | https://conductscience.org/library/papers/38814416 | PubMed |
| 38732026 | Balancing Benefits and Risks: A Literature Review on Hypersensitivity Reactions to Human G-CSF (Granulocyte Colony-Stimulating Factor). | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38732026 | PubMed |
| 38672505 | Thrombopoietin, the Primary Regulator of Platelet Production: From Mythos to Logos, a Thirty-Year Journey. | Biomolecules | 2024 | https://conductscience.org/library/papers/38672505 | PubMed |
| 38556793 | CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia. | Mol Ther | 2024 | https://conductscience.org/library/papers/38556793 | PubMed |
| 37638739 | Improving the Therapeutic Potential of G-CSF through Compact Circular PEGylation Based on Orthogonal Conjugations. | Biomacromolecules | 2023 | https://conductscience.org/library/papers/37638739 | PubMed |
| 36951655 | Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122). | Cancer Med | 2023 | https://conductscience.org/library/papers/36951655 | PubMed |
| 36313476 | Peptide ILE-GLU-TRP (Stemokin) Potential Adjuvant Stimulating a Balanced Immune Response. | Int J Pept Res Ther | 2022 | https://conductscience.org/library/papers/36313476 | PubMed |
| 35739328 | Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF). | Support Care Cancer | 2022 | https://conductscience.org/library/papers/35739328 | PubMed |
| 35618709 | A topological refactoring design strategy yields highly stable granulopoietic proteins. | Nat Commun | 2022 | https://conductscience.org/library/papers/35618709 | PubMed |
| 35324270 | Biosimilar Versus Originator Pegfilgrastim for Preventing Chemotherapy-Induced Neutropenia: A Phase III Randomized, Multicenter, Evaluator-Blinded, Noninferiority Study. | JCO Glob Oncol | 2022 | https://conductscience.org/library/papers/35324270 | PubMed |
| 34631440 | Hematopoietic stem cell mobilization strategies to support high-dose chemotherapy: A focus on relapsed/refractory germ cell tumors. | World J Clin Oncol | 2021 | https://conductscience.org/library/papers/34631440 | PubMed |
| 33923357 | The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33923357 | PubMed |
| 33789928 | Viral Respiratory Pathogens and Lung Injury. | Clin Microbiol Rev | 2021 | https://conductscience.org/library/papers/33789928 | PubMed |
| 33787864 | Minimally myelosuppressive regimen for remission induction in pediatric AML: long-term results of an observational study. | Blood Adv | 2021 | https://conductscience.org/library/papers/33787864 | PubMed |
| 33677228 | G-CSF in tumors: Aggressiveness, tumor microenvironment and immune cell regulation. | Cytokine | 2021 | https://conductscience.org/library/papers/33677228 | PubMed |
| 33598399 | Fludarabine-based salvage therapy for refractory/relapsed acute leukemias: A single center experience. | Leuk Res Rep | 2021 | https://conductscience.org/library/papers/33598399 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CSF3 | 1440 | Swiss-Prot's references | https://conductscience.org/library/genes/1440 |
Source NCBI Gene
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GENBANK | M13008 |
Source GENBANK
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2420009
GET https://conductscience.org/api/papers/v1/2420009/cited_by?page=2